Found: 10
Select item for more details and to access through your institution.
Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Predictors of Placebo Group Decline in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) in 24 Week Clinical Trials of Alzheimer's Disease.
- Published in:
- Journal of Alzheimer's Disease, 2008, v. 14, n. 3, p. 301, doi. 10.3233/JAD-2008-14304
- By:
- Publication type:
- Article
Machine Learning and Pharmacometrics for Prediction of Pharmacokinetic Data: Differences, Similarities and Challenges Illustrated with Rifampicin.
- Published in:
- Pharmaceutics, 2022, v. 14, n. 8, p. 1530, doi. 10.3390/pharmaceutics14081530
- By:
- Publication type:
- Article
Effect of 6 months of monotherapy with the 5HT6 receptor antagonist SB-742457 or donepezil in subjects with mild-to-moderate Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Effects of 6-month monotherapy treatment with the 5HT6 receptor antagonist SB 742457 or donepezil in subjects with mild-to-moderate Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Use of the RBANS as a cognitive endpoint in Alzheimer clinical trials
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P4-373: Predictors of placebo group decline in the Alzheimer's disease assessment scale-cognitive subscale (ADAS-cog) in 24-week clinical trials of Alzheimer's disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P4-341: Efficacy and tolerability of SB-742457, a novel 5HT<sub>6</sub> receptor antagonist, and Donepezil in subjects with mild-to-moderate Alzheimer's disease (AD)
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O3-04-06: Efficacy and tolerability of SB-742457, a novel 5HT<sub>6</sub> receptor antagonist, in subjects with mild-to-moderate Alzheimer's disease (AD)
- Published in:
- 2008
- By:
- Publication type:
- Abstract
SB-742457 and donepezil in Alzheimer disease: a randomized, placebo-controlled study.
- Published in:
- International Journal of Geriatric Psychiatry, 2011, v. 26, n. 5, p. 536, doi. 10.1002/gps.2562
- By:
- Publication type:
- Article